What is Mdxhealth Sa share price today?

Mdxhealth Sa (MDXH) share price today is {{live_price}}.

Can Indians buy Mdxhealth Sa shares?

Yes, Indians can invest in the Mdxhealth Sa (MDXH) from India. With INDmoney, you can buy Mdxhealth Sa at 0 brokerage. The step-by-step process is as follows: Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes) Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates. Once funds are transferred successfully, you can buy Mdxhealth Sa at zero transaction cost.

How can I buy Mdxhealth Sa shares from India?

It is very easy to buy Mdxhealth Sa from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Mdxhealth Sa be purchased?

Yes, you can buy fractional shares of Mdxhealth Sa with INDmoney app.

What are the documents required to start investing in Mdxhealth Sa stocks?

To start investing in Mdxhealth Sa, You will need the following documents: Proof of Identification (PAN, Aadhaar etc) Proof of address (Aadhaar, Voter ID etc) These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Mdxhealth Sa

Today’s highest price of Mdxhealth Sa (MDXH) is {{1_rba_end}}. Today’s lowest price of Mdxhealth Sa (MDXH) is {{1_rba_st}}.

What is today's market capitalisation of Mdxhealth Sa

Today's market capitalisation of Mdxhealth Sa MDXH is 94.8M

What is the 52 Week High and Low Range of Mdxhealth Sa

52 Week High {{rba_end}} 52 Week Low {{rba_st}}

How much percentage Mdxhealth Sa is down from its 52 Week High?

Mdxhealth Sa (MDXH) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

How much percentage Mdxhealth Sa is up from its 52 Week low?

Mdxhealth Sa (MDXH) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

What are the historical returns of Mdxhealth Sa?

1 Month Returns {{1mr}}% 3 Months Returns {{3mr}}% 1 Year Returns {{1yr}}% 5 Years Returns {{5yr}}%

Who is the Chief Executive Officer (CEO) of Mdxhealth Sa

Mr. Michael K. McGarrity is the current Chief Executive Officer (CEO) of Mdxhealth Sa.

Home>
US Stocks>
Mdxhealth Sa

Mdxhealth Sa (MDXH)

Market is closed - opens 7 PM, 07 Oct 2024

Performance

$1.99
$2.02
$2.00
0.75%
Downside
Day's Volatility :1.73%
Upside
0.99%
$1.95
$32.25
$2.00
2.5%
Downside
52 Weeks Volatility :93.95%
Upside
93.8%

Returns

Period	Mdxhealth Sa	Sector (Health Care)	Index (Russel 2000)
3 Months	-29.58%	4.9%	0.0%
6 Months	-21.88%	5.8%	0.0%
1 Year	-91.63%	16.5%	0.0%
3 Years	-83.33%	20.3%	-20.1%

Highlights

Market Capitalization	94.8M
Book Value	- $0.32
Earnings Per Share (EPS)	-1.48
Wall Street Target Price	8.44

Profit Margin	-50.54%
Operating Margin TTM	-32.38%

Return On Assets TTM	-11.0%
Return On Equity TTM	-457.29%

Revenue TTM	80.7M
Revenue Per Share TTM	2.95
Quarterly Revenue Growth YOY	32.300000000000004%
Gross Profit TTM	19.2M
EBITDA	-18.6M
Diluted Eps TTM	-1.48
Quarterly Earnings Growth YOY	0.0

EPS Estimate Current Year	-1.17
EPS Estimate Next Year	-0.72
EPS Estimate Current Quarter	-0.26
EPS Estimate Next Quarter	-0.23

Analyst Recommendation

Buy

91%Buy

8%Hold

0%Sell

Based on 12 Wall street analysts offering stock ratings for Mdxhealth Sa(by analysts ranked 0 to 5 stars)

Based on 12 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast

What analysts predicted

Upside of 322.0%

Current $2.00

Target $8.44

Company Financials

	FY18	Y/Y Change
Revenue	28.3M	↓ 30.04%
Net Income	-32.5M	↑ 164.08%
Net Profit Margin	-114.51%	↓ 84.18%

	FY19	Y/Y Change
Revenue	11.8M	↓ 58.41%
Net Income	-43.1M	↑ 32.82%
Net Profit Margin	-365.72%	↓ 251.21%

	FY20	Y/Y Change
Revenue	18.4M	↑ 55.89%
Net Income	-30.0M	↓ 30.38%
Net Profit Margin	-163.33%	↑ 202.39%

	FY21	Y/Y Change
Revenue	22.2M	↑ 21.05%
Net Income	-30.9M	↑ 2.9%
Net Profit Margin	-138.84%	↑ 24.49%

	FY22	Y/Y Change
Revenue	37.1M	↑ 66.62%
Net Income	-50.2M	↑ 62.54%
Net Profit Margin	-135.45%	↑ 3.39%

	FY23	Y/Y Change
Revenue	70.2M	↑ 89.43%
Net Income	-43.1M	↓ 14.12%
Net Profit Margin	-61.4%	↑ 74.05%

	Q1 FY23	Q/Q Change
Revenue	12.9M	↑ 0.0%
Net Income	-12.4M	↑ 0.0%
Net Profit Margin	-96.49%	↑ 0.0%

	Q2 FY23	Q/Q Change
Revenue	16.7M	↑ 29.9%
Net Income	-10.6M	↓ 14.57%
Net Profit Margin	-63.46%	↑ 33.03%

	Q3 FY23	Q/Q Change
Revenue	19.4M	↑ 15.56%
Net Income	-10.0M	↓ 5.47%
Net Profit Margin	-51.91%	↑ 11.55%

	Q4 FY23	Q/Q Change
Revenue	19.4M	↑ 0.25%
Net Income	-10.7M	↑ 6.72%
Net Profit Margin	-55.26%	↓ 3.35%

	Q1 FY24	Q/Q Change
Revenue	19.8M	↑ 2.25%
Net Income	-8.5M	↓ 20.61%
Net Profit Margin	-42.91%	↑ 12.35%

	Q2 FY24	Q/Q Change
Revenue	22.2M	↑ 11.72%
Net Income	-11.5M	↑ 35.45%
Net Profit Margin	-52.02%	↓ 9.11%

	FY18	Y/Y Change
Total Assets	65.5M	↑ 11.88%
Total Liabilities	13.4M	↓ 10.79%

	FY19	Y/Y Change
Total Assets	40.6M	↓ 37.95%
Total Liabilities	20.9M	↑ 56.48%

	FY20	Y/Y Change
Total Assets	31.9M	↓ 21.59%
Total Liabilities	26.0M	↑ 24.41%

	FY21	Y/Y Change
Total Assets	75.1M	↑ 135.66%
Total Liabilities	28.2M	↑ 8.33%

	FY22	Y/Y Change
Total Assets	119.1M	↑ 58.69%
Total Liabilities	109.8M	↑ 289.81%

	FY23	Y/Y Change
Total Assets	129.1M	↑ 8.39%
Total Liabilities	121.9M	↑ 11.02%

	Q1 FY23	Q/Q Change
Total Assets	119.1M	↑ 0.0%
Total Liabilities	109.8M	↑ 0.0%

	Q2 FY23	Q/Q Change
Total Assets	142.5M	↑ 19.65%
Total Liabilities	115.9M	↑ 5.52%

	Q3 FY23	Q/Q Change
Total Assets	135.7M	↓ 4.78%
Total Liabilities	117.9M	↑ 1.73%

	Q4 FY23	Q/Q Change
Total Assets	129.1M	↓ 4.86%
Total Liabilities	121.9M	↑ 3.42%

	Q1 FY24	Q/Q Change
Total Assets	121.7M	↓ 5.72%
Total Liabilities	122.7M	↑ 0.65%

	Q2 FY24	Q/Q Change
Total Assets	130.9M	↑ 7.49%
Total Liabilities	139.7M	↑ 13.81%

	FY18	Y/Y Change
Operating Cash Flow	-28.5M	↑ 172.12%
Investing Cash Flow	-1.3M	↓ 77.45%
Financing Cash Flow	41.7M	↑ 7172.6%

	FY19	Y/Y Change
Operating Cash Flow	-22.3M	↓ 21.91%
Investing Cash Flow	-73.0K	↓ 94.57%
Financing Cash Flow	18.0M	↓ 56.89%

	FY20	Y/Y Change
Operating Cash Flow	-20.2M	↓ 9.17%
Investing Cash Flow	-537.0K	↑ 635.62%
Financing Cash Flow	14.3M	↓ 20.46%

	FY21	Y/Y Change
Operating Cash Flow	-22.5M	↑ 11.38%
Investing Cash Flow	-1.2M	↑ 124.95%
Financing Cash Flow	66.5M	↑ 365.35%

	FY22	Y/Y Change
Operating Cash Flow	-34.1M	↑ 51.31%
Investing Cash Flow	-29.2M	↑ 2314.16%
Financing Cash Flow	20.8M	↓ 68.66%

	Q1 FY23	Q/Q Change
Operating Cash Flow	-9.7M	↑ 0.0%
Investing Cash Flow	-1.2M	↓ 44.58%
Financing Cash Flow	-20.0K	↑ 0.0%

	Q2 FY23	Q/Q Change
Operating Cash Flow	-5.6M	↓ 42.48%
Investing Cash Flow	-1.6M	↑ 26.73%
Financing Cash Flow	-1.4M	↑ 7040.0%

Technicals Summary

Sell

Neutral

Buy

Mdxhealth Sa is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Mdxhealth Sa	-29.33%	-21.88%	-91.63%	-83.33%	-83.33%
Idexx Laboratories, Inc.	2.36%	-6.06%	8.42%	-21.66%	77.73%
Agilent Technologies Inc.	5.36%	0.06%	30.65%	-5.92%	92.48%
Thermo Fisher Scientific, Inc.	-1.7%	3.82%	20.53%	4.4%	107.82%
Danaher Corp.	1.62%	10.76%	24.53%	-10.01%	93.67%
Iqvia Holdings Inc.	-6.45%	-5.84%	14.48%	-5.01%	52.93%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Mdxhealth Sa	NA	NA	NA	-1.17	-4.57	-0.11	NA	-0.32
Idexx Laboratories, Inc.	47.87	47.87	5.09	10.59	0.63	0.23	NA	19.16
Agilent Technologies Inc.	30.05	30.05	3.16	5.24	0.25	0.08	0.01	20.53
Thermo Fisher Scientific, Inc.	38.03	38.03	2.28	21.73	0.14	0.05	0.0	124.17
Danaher Corp.	50.26	50.26	2.71	7.59	0.08	0.04	0.0	68.92
Iqvia Holdings Inc.	29.57	29.57	1.15	11.2	0.23	0.05	NA	36.83

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Mdxhealth Sa	Buy	$94.8M	-83.33%	NA	-50.54%
Idexx Laboratories, Inc.	Buy	$40.0B	77.73%	47.87	22.34%
Agilent Technologies Inc.	Buy	$42.1B	92.48%	30.05	21.75%
Thermo Fisher Scientific, Inc.	Buy	$234.1B	107.82%	38.03	14.69%
Danaher Corp.	Buy	$197.8B	93.67%	50.26	17.83%
Iqvia Holdings Inc.	Buy	$41.5B	52.93%	29.57	9.39%

Insights on Mdxhealth Sa

Increasing Revenue
Revenue is up for the last 12 quarters, 5.49M → 22.15M (in $), with an average increase of 11.1% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -8.51M → -11.52M (in $), with an average decrease of 35.5% per quarter
Vs A
In the last 1 year, Agilent Technologies Inc. has given 30.6% return, outperforming this stock by 122.2%

Mdxhealth Sa (MDXH)

Performance

Returns

Highlights

Analyst Recommendation

Analyst Forecast

Company Financials

Technicals Summary

Peers

Increasing Revenue

Decreasing Net Profit

Vs A

Institutional Holdings

Company Information

Discover More

FAQs

Organization	Mdxhealth Sa
Employees	300
CEO	Mr. Michael K. McGarrity
Industry	Healthcare